PF-06821497 | Interleukin Related interleukin-related.com

Product Name :
PF-06821497

Search keywords :
PF-06821497

drugId :
null

Target Vo:
Histone-lysine N-methyltransferase EZH2

Target Vo Short Name :
EZH2

Moa_Name:
Histone-lysine N-methyltransferase EZH2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pfizer Inc

Active Company_Name :
Pfizer Inc

Active Indication_Name:
Lymphoma, Follicular

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Galectin 1 Rabbit mAb Cancer
Nrf2 Antibody(YA895) Purity & Documentation
E2 Tag Antibody (YA870): E2 Tag Antibody (YA870) is an unconjugated, mouse-derived, anti-E2 Tag (YA870) monoclonal antibody. E2 Tag Antibody (YA870) can be used for: WB expriments in species-independent background without labeling.

Author: Interleukin Related

Related Posts